Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Prevention
Reports outline anthrax prevention study results from Centers for Disease Control and Prevention
May 18th, 2008
New investigation results, 'Conference report on public health and clinical guidelines for anthrax,' are detailed in a study published in Emerging Infectious Diseases. "On March 13-14, 2006, a meeting on anthrax, sponsored by the Centers for Disease Control and Prevention (CDC) in collaboration with the Southeastern Center for Emerging Biologic Threats, was held at Emory University in Atlanta, Georgia, USA. The meeting's agenda included discussion of postexposure prophylaxis (PEP), screening and evaluation, and treatment of the various manifestations of human anthrax," scientists in the United States report. "The goal was to convene subject matter experts for a...
Source: Medical Letter on the CDC & FDA (2008-05-18)
|
